328 related articles for article (PubMed ID: 22693311)
21. Tumor targeting by an aptamer.
Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
[TBL] [Abstract][Full Text] [Related]
22. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
23. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.
Fisher RE; Siegel BA; Edell SL; Oyesiku NM; Morgenstern DE; Messmann RA; Amato RJ
J Nucl Med; 2008 Jun; 49(6):899-906. PubMed ID: 18483093
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic Properties of
Larenkov A; Rakhimov M; Lunyova K; Klementyeva O; Maruk A; Machulkin A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545327
[TBL] [Abstract][Full Text] [Related]
25. Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages.
Henne WA; Rothenbuhler R; Ayala-Lopez W; Xia W; Varghese B; Low PS
Mol Pharm; 2012 May; 9(5):1435-40. PubMed ID: 22468849
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
27. Expression of functional folate receptors by human parathyroid cells.
Weber CJ; Müller S; Safley SA; Gordon KB; Amancha P; Villinger F; Camp VM; Lipowska M; Sharma J; Müller C; Schibli R; Low PS; Leamon CP; Halkar RK
Surgery; 2013 Dec; 154(6):1385-93; discussion 1393. PubMed ID: 24206618
[TBL] [Abstract][Full Text] [Related]
28. Radiolabeling of folic acid-modified chitosan with (99m)Tc as potential agents for folate-receptor-mediated targeting.
Guo W; Jing H; Yang W; Guo Z; Feng S; Zhang X
Bioorg Med Chem Lett; 2011 Nov; 21(21):6446-50. PubMed ID: 21920738
[TBL] [Abstract][Full Text] [Related]
29. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
30. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.
Müller C; Hohn A; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1007-16. PubMed ID: 16763819
[TBL] [Abstract][Full Text] [Related]
32. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
33. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
Aranda-Lara L; Ferro-Flores G; Ramírez Fde M; Ocampo-García B; Santos-Cuevas C; Díaz-Nieto L; Isaac-Olivé K
Nucl Med Commun; 2016 Apr; 37(4):377-86. PubMed ID: 26657220
[TBL] [Abstract][Full Text] [Related]
34. Development of
Lodhi NA; Park JY; Hong MK; Kim YJ; Lee YS; Cheon GJ; Jeong JM
Bioorg Med Chem; 2019 May; 27(10):1925-1931. PubMed ID: 30992201
[TBL] [Abstract][Full Text] [Related]
35. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent.
Kelderhouse LE; Robins MT; Rosenbalm KE; Hoylman EK; Mahalingam S; Low PS
Mol Pharm; 2015 Oct; 12(10):3547-55. PubMed ID: 26333010
[TBL] [Abstract][Full Text] [Related]
38. Radiolabeling of folate targeted multifunctional conjugate with Technetium-99m and biodistribution studies in rats.
Ak G; Yurt Lambrecht F; Sanlier SH
J Drug Target; 2012 Jul; 20(6):509-14. PubMed ID: 22643314
[TBL] [Abstract][Full Text] [Related]
39. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18.
Boss SD; Betzel T; Müller C; Fischer CR; Haller S; Reber J; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2016 Jan; 27(1):74-86. PubMed ID: 26634288
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
